Dr. Norambuena received his Ph.D. in Cellular and Molecular Biology from Pontificia Universidad Católica de Chile (PUC) in 2006. Then, he completed a postdoctoral training in animal physiology (2006-2008) at PUC and received further training in the lab of Dr. Martin Schwartz at the University of Virginia (2008-2011). His longstanding interest in cellular and molecular mechanism of Alzheimer’s disease started in the laboratory of Dr. George Bloom where he currently works independently as a Senior Scientist. Presently, Dr. Norambuena is exploring how extracellular and oligomeric forms of amyloid beta and tau disrupt mitochondrial metabolism at presymptomatic stages of Alzheimer’s disease.